Pure Global AI
ANVISA registration 10287411786Valid until Apr 22, 2036

IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS

ANVISA Registration Number: 10287411786ROCHE DIAGNÓSTICA BRASIL LTDACELL MARQUE CORPORATIONRisk Class III
Verified
Device names
Technical name
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
View exact technical-name matches →
PT: IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Commercial name
Família Marcadores de Linfomas e Leucemias - CM I
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10287411786
Process Number
25351012984202660
CNPJ
30280358000186
Company information
Registration Holder
ROCHE DIAGNÓSTICA BRASIL LTDA
Manufacturer
CELL MARQUE CORPORATION
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Apr 22, 2026
Validity
22/04/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411786 and manufactured by CELL MARQUE CORPORATION. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Apr 22, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.